Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of SeaStar Medical Holding Corporation (ICU) InvestorsBusiness Wire • 07/15/24
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICUGlobeNewsWire • 07/14/24
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SeaStar and Bolt and Encourages Investors to Contact the FirmGlobeNewsWire • 07/14/24
ICU Investors Are Presented With The Chance To Spearhead The Securities Fraud Legal Case Against SeaStar Medical Holding Corporation With The Schall Law FirmAccesswire • 07/13/24
ICU SHAREHOLDER ALERT: Edelson Lechtzin LLP Urges SeaStar Medical Holding Corporation (NASDAQ: ICU, ICUCW) Shareholders to Consult Legal Counsel About the Pending Securities Fraud Class ActionPRNewsWire • 07/12/24
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of SeaStar Medical Holding Corporation (ICU) InvestorsBusiness Wire • 07/12/24
SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution PartnerGlobeNewsWire • 07/12/24
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICUGlobeNewsWire • 07/11/24
ICU Investors Given Opportunity To Lead SeaStar Medical Holding Corporation Securities Fraud Legal Case With The Schall Law FirmAccesswire • 07/11/24
SeaStar Medical Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGlobeNewsWire • 07/11/24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of SeaStar Medical Holding Corporation (ICU) on Behalf of InvestorsBusiness Wire • 07/11/24
ICU Investors Are Presented With The Chance To Spearhead SeaStar Medical Holding Corporation Securities Fraud Legal Action With The Schall Law FirmAccesswire • 07/11/24
ICU Investors Have Opportunity to Lead SeaStar Medical Holding Corporation. Securities Fraud LawsuitPRNewsWire • 07/10/24
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of SeaStar Medical Holding Corporation (ICU) on Behalf of InvestorsBusiness Wire • 07/10/24
SeaStar Medical Holding Corporation Investors: Robbins LLP Reminds Shareholders of the SeaStar Medical Holding Corporation (ICU) Class ActionBusiness Wire • 07/10/24
The Law Offices of Frank R. Cruz Announces Investigation of SeaStar Medical Holding Corporation (ICU) on Behalf of InvestorsBusiness Wire • 07/10/24
SEASTAR ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against SeaStar Medical Holding Corporation and Encourages Investors to Contact the FirmGlobeNewsWire • 07/10/24
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against SeaStar Medical Holding CorporationGlobeNewsWire • 07/09/24
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against SeaStar Medical Holding Corporation (ICU)GlobeNewsWire • 07/09/24
Rosen Law Firm Urges SeaStar Medical Holding Corporation (ICU, ICUCW) Stockholders with Large Losses to Contact the Firm for Information About Their RightsBusiness Wire • 07/09/24
Class Action Lawsuit Filed on Behalf of SeaStar Medical Holding Corporation (ICU) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmGlobeNewsWire • 07/08/24
SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use DeviceGlobeNewsWire • 07/03/24
SeaStar Medical's Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care NephrologyGlobeNewsWire • 06/11/24
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage CompanyGlobeNewsWire • 06/10/24
Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical's Selective Cytopheretic Device in the Immunomodulation of Excessive InflammationGlobeNewsWire • 06/07/24